Vasavada, A.; Sadhu, A.; Valencia, C.; Fatima, H.; Nwankwo, I.; Anam, M.; Maharjan, S.; Amjad, Z.; Abaza, A.; Khan, S.
Effect of Sacubitril-Valsartan on Quality of Life, Functional and Exercise Capacity in Heart Failure with Preserved Ejection Fraction (HFpEF): A Systematic Review of Randomized Clinical Trials. Hearts 2022, 3, 129-136.
https://doi.org/10.3390/hearts3040015
AMA Style
Vasavada A, Sadhu A, Valencia C, Fatima H, Nwankwo I, Anam M, Maharjan S, Amjad Z, Abaza A, Khan S.
Effect of Sacubitril-Valsartan on Quality of Life, Functional and Exercise Capacity in Heart Failure with Preserved Ejection Fraction (HFpEF): A Systematic Review of Randomized Clinical Trials. Hearts. 2022; 3(4):129-136.
https://doi.org/10.3390/hearts3040015
Chicago/Turabian Style
Vasavada, Advait, Akhil Sadhu, Carla Valencia, Hameeda Fatima, Ijeoma Nwankwo, Mahvish Anam, Shrinkhala Maharjan, Zainab Amjad, Abdelrahman Abaza, and Safeera Khan.
2022. "Effect of Sacubitril-Valsartan on Quality of Life, Functional and Exercise Capacity in Heart Failure with Preserved Ejection Fraction (HFpEF): A Systematic Review of Randomized Clinical Trials" Hearts 3, no. 4: 129-136.
https://doi.org/10.3390/hearts3040015
APA Style
Vasavada, A., Sadhu, A., Valencia, C., Fatima, H., Nwankwo, I., Anam, M., Maharjan, S., Amjad, Z., Abaza, A., & Khan, S.
(2022). Effect of Sacubitril-Valsartan on Quality of Life, Functional and Exercise Capacity in Heart Failure with Preserved Ejection Fraction (HFpEF): A Systematic Review of Randomized Clinical Trials. Hearts, 3(4), 129-136.
https://doi.org/10.3390/hearts3040015